Dr Lesley Ann Ogilvie

Global AMR R&D Hub

Lesley Ann Ogilvie is Director of the Secretariat at the Global Antimicrobial Resistance Research and Development Hub (Global AMR R&D Hub), a global partnership focused on addressing challenges and improving co-ordination and collaboration in AMR research and development using a One Health approach. She is a microbiologist by training with a PhD from the University of East Anglia and over 15 years experience as a researcher and lecturer at the University of Brighton and the Max Planck Institute for Molecular Genetics. Her research focus has been the role of the human gut virome/microbiome in health and disease and the discovery and characterisation of therapeutic phage. Lesley represents the Global AMR R&D Hub on a number of advisory groups, including for the World Health Organisation and the European Commission, and is a member of the Applied Microbiology International One Health Advisory Group.